These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 12529274)
1. Angiotensin II and renal medullary blood flow in Lyon rats. Sarkis A; Liu KL; Lo M; Benzoni D Am J Physiol Renal Physiol; 2003 Feb; 284(2):F365-72. PubMed ID: 12529274 [TBL] [Abstract][Full Text] [Related]
2. Effect of perindopril on renal medullary hemodynamics in genetically hypertensive rats. Liu KL; Lo M; Benzoni D Am J Hypertens; 2006 Jun; 19(6):617-22. PubMed ID: 16733235 [TBL] [Abstract][Full Text] [Related]
3. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat. Clayton JS; Clark KL; Johns EJ; Drew GM Br J Pharmacol; 1998 Aug; 124(7):1467-74. PubMed ID: 9723960 [TBL] [Abstract][Full Text] [Related]
4. AT2-antagonist sensitive potentiation of angiotensin II-induced vasoconstrictions by blockade of nitric oxide synthesis in rat renal vasculature. Muller C; Endlich K; Barthelmebs M; Helwig JJ Br J Pharmacol; 1997 Dec; 122(7):1495-501. PubMed ID: 9421301 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the vasodilatory effects of bradykinin in isolated dog renal arteries and in buffer-perfused dog kidneys. Malomvölgyi B; Hadházy P; Tekes K; Koltai MZ; Pogátsa G Acta Physiol Hung; 1996; 84(1):9-18. PubMed ID: 8993670 [TBL] [Abstract][Full Text] [Related]
6. Differential effect of angiotensin II on blood circulation in the renal medulla and cortex of anaesthetised rats. Badzyńska B; Grzelec-Mojzesowicz M; Dobrowolski L; Sadowski J J Physiol; 2002 Jan; 538(Pt 1):159-66. PubMed ID: 11773324 [TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats. De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin II type 2 receptor-mediated inhibition of norepinephrine release in isolated rat hearts. Sasaoka T; Egi Y; Tawa M; Yamamoto A; Ohkita M; Takaoka M; Maruyama T; Akira T; Matsumura Y J Cardiovasc Pharmacol; 2008 Aug; 52(2):176-83. PubMed ID: 18670361 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists. Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358 [TBL] [Abstract][Full Text] [Related]
10. Prostaglandins but not nitric oxide protect renal medullary perfusion in anaesthetised rats receiving angiotensin II. Badzyńska B; Grzelec-Mojzesowicz M; Sadowski J J Physiol; 2003 May; 548(Pt 3):875-80. PubMed ID: 12640010 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin II-mediated vasodilation is reduced in adult spontaneously hypertensive rats despite enhanced expression of AT2 receptors. Ognibene DT; Oliveira PR; Marins de Carvalho LC; Costa CA; Espinoza LA; Criddle DN; Tano T; Soares de Moura R; Resende AC Clin Exp Pharmacol Physiol; 2009 Jan; 36(1):12-9. PubMed ID: 18986337 [TBL] [Abstract][Full Text] [Related]
12. Protective effect of angiotensin II-induced increase in nitric oxide in the renal medullary circulation. Zou AP; Wu F; Cowley AW Hypertension; 1998 Jan; 31(1 Pt 2):271-6. PubMed ID: 9453315 [TBL] [Abstract][Full Text] [Related]
13. Acute renal excretory actions of losartan in spontaneously hypertensive rats: role of AT2 receptors, prostaglandins, kinins and nitric oxide. Munoz-Garcia R; Maeso R; Rodrigo E; Navarro J; Ruilope LM; Casal MC; Cachofeiro V; Lahera V J Hypertens; 1995 Dec; 13(12 Pt 2):1779-84. PubMed ID: 8903651 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin II and neurohumoral control of the renal medullary circulation. Evans RG; Head GA; Eppel GA; Burke SL; Rajapakse NW Clin Exp Pharmacol Physiol; 2010 Feb; 37(2):e58-69. PubMed ID: 19566838 [TBL] [Abstract][Full Text] [Related]
15. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors. Hartman JC Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893 [TBL] [Abstract][Full Text] [Related]
16. Regulation of renal medullary circulation by the renin-angiotensin system in genetically hypertensive rats. Liu KL Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):455-61. PubMed ID: 19215237 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin II-induced venoconstriction involves both AT1 and AT2 receptors and is counterbalanced by nitric oxide. Fernandes L; Loiola RA; Tostes RC; Nigro D; Fortes ZB; de Carvalho MH Peptides; 2005 Dec; 26(12):2458-63. PubMed ID: 16043265 [TBL] [Abstract][Full Text] [Related]
18. AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Gohlke P; Pees C; Unger T Hypertension; 1998 Jan; 31(1 Pt 2):349-55. PubMed ID: 9453327 [TBL] [Abstract][Full Text] [Related]
19. NO-independent mechanism mediates tempol-induced renal vasodilation in SHR. de Richelieu LT; Sorensen CM; Holstein-Rathlou NH; Salomonsson M Am J Physiol Renal Physiol; 2005 Dec; 289(6):F1227-34. PubMed ID: 16033921 [TBL] [Abstract][Full Text] [Related]
20. Local renal medullary L-NAME infusion enhances the effect of long-term angiotensin II treatment. Szentiványi M; Maeda CY; Cowley AW Hypertension; 1999 Jan; 33(1 Pt 2):440-5. PubMed ID: 9931144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]